Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency
about
Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor ModelEx vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cellsOptimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study.Tumor vaccines for breast cancerTherapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.all-trans-retinoic acid improves immunocompetence in a murine model of lipopolysaccharide-induced immunosuppression.CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapyNonneuronal Cholinergic System in Breast Tumors and Dendritic Cells: Does It Improve or Worsen the Response to Tumor?
P2860
Q33730717-5BEEC012-08F4-4B11-B859-FC03871AE4CAQ34343680-ECBDD844-2EA0-4349-AA92-8A7DFFAA8B2DQ34419349-901084AB-104E-4C8A-9BE3-4E555AB5271EQ35144428-34FEC5D1-5B5A-468A-B7D2-09AD0F60537EQ36038020-9A8D1348-2DC4-406A-8260-A137521D4F9DQ36204803-CF131847-3B44-4D26-9734-D5876B376C69Q36869774-14BCA401-2226-47E5-9EAA-C4ED44765C2AQ38269370-B8572F61-4764-4C69-A36A-3870EB0E4A78Q38875030-E68954C9-D61B-4345-857D-4D222263835FQ51782457-6D709633-45C0-4C63-961C-4661127CC99EQ58565339-81045E31-C422-42C1-AE4D-376B3AEAE853Q58997331-B532EB14-E201-40C5-BDD2-644A96C88F02
P2860
Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dendritic cells are defective ...... amine in this immunodeficiency
@ast
Dendritic cells are defective ...... amine in this immunodeficiency
@en
Dendritic cells are defective ...... amine in this immunodeficiency
@nl
type
label
Dendritic cells are defective ...... amine in this immunodeficiency
@ast
Dendritic cells are defective ...... amine in this immunodeficiency
@en
Dendritic cells are defective ...... amine in this immunodeficiency
@nl
prefLabel
Dendritic cells are defective ...... amine in this immunodeficiency
@ast
Dendritic cells are defective ...... amine in this immunodeficiency
@en
Dendritic cells are defective ...... amine in this immunodeficiency
@nl
P2093
P2860
P356
P1476
Dendritic cells are defective ...... amine in this immunodeficiency
@en
P2093
Alban Gervais
Florence Burtin
Françoise Bouet-Toussaint
Jean Levêque
Laurent Sulpice
Noelle Genetet
Thierry Lesimple
Véronique Catros-Quemener
P2860
P2888
P304
P356
10.1186/BCR1001
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1053495668